Introduction: Congenital pyloric atresia (CPA) is a rare gastrointestinal system anomaly characterized by gastric outlet obstruction. This study evaluated patients operated for CPA in the past 15 years. The impact of use or non-use of transanastomotic feeding tubes (TATs) on the follow-up results was examined. Material and Method: Patients operated for CPA between 2005 and 2020 were evaluated. Further, cases in whom TATs were used and cases in whom TATs were not used were evaluated in two sub-groups. The impact of presence orabsence of TATs on postoperative follow-up results was examined. Results: In this study, a total of 12 patients consisting of 7 boys and 5 girls were evaluated. The mean birth week was 35.1 ± 2.4 (31-38) weeks and the mean birth weight was 2602.9 ± 599.6 (1680-3620) grams. The mean time of operation was postnatal 3.8 (1-10) days. Among the cases, 8 (66.7%) had type 1 atresia, and 4 (33.3%) had type 2 atresia. Heineke-Mikulicz pyloroplasty was performed on 9 (75%) cases, and gastroduodenostomy was performed on 3 (25%) cases. 4 (33.2%) patients had various additional anomalies. The patient with EB (8.3%) died due to sepsis in the early postoperative phase. In 8 cases (66.7%), intraoperative TAT placement was performed. In cases with TATs, the time to postoperative feeding and length of stay were statistically determined to be lower. Discussion: Pyloric atresia is a rare intestinal system obstruction. Comorbidity with congenital anomalies increases mortality. Intraoperative TAT insertion enables early enteral feeding. Keywors: Congenital pyloric atresia, gastrointestinal system, transanastomotic feeding tubes
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.